Modern drugs and schizophrenia
Labhardt, F.; Wyss, P.
Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 113(2): 398-400
1973
ISSN/ISBN: 0036-7273 PMID: 4776677 Document Number: 70217
Document emailed within 1 workday
Related Documents
Roxo, H. 1952: Pseudoneurotics; patients at the onset of schizophrenia; differential diagnosis of neurasthenia and schizophrenia; modern therapy Imprensa Medica 28(463): 25-30Horgan, J.H.; Teo, K.K.; Harte, M. 1982: Modern drugs treatment--No. 11. Antiarrhythmic drugs Irish Medical Journal 75(11): 426-427; 429-432
Hashimoto, K.; Iyo, M. 2002: Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs Nihon Shinkei Seishin Yakurigaku Zasshi 22(1): 3-13
Weiden, P.; Aquila, R.; Standard, J. 1996: Atypical antipsychotic drugs and long-term outcome in schizophrenia Journal of Clinical Psychiatry 57(Suppl): 53-60
Sayed, Y.; Garrison, J.M. 1983: The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review Psychopharmacology Bulletin 19(2): 283-288
Jarema, M.; Murawiec, S.; Szafrański, T.; Szaniawska, A.; Konieczyńska, Z. 2001: Subjective and objective evaluation of treating schizophrenia with classic or atypical drugs Psychiatria Polska 35(1): 5-19
Garner, A. 1994: Development of modern anti-ulcer drugs British Journal of Clinical Practice. Suppl 75: 1-5; Discussion: 6-8
Vorberg, G. 1973: A combination of 3 drugs for modern treatment of hypertension Medizinische Monatsschrift 27(9): 418-420
Janowsky, D.S.; Davis, J.M.; Huey, L.; Judd, L.L. 1979: Adrenergic and cholinergic drugs as episode and vulnerability markers of affective disorders and schizophrenia Psychopharmacology Bulletin 15(1): 33-34
Tsygankov, B.D.; Agasarain, E.G.; Zykova, A.S. 2014: Antipsychotic drugs and their influence on the carbohydrate metabolism in patients with schizophrenia-spectrum disorders Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(5): 86-91
Sobolev, E.S.; Zaĭtsev, S.G. 1981: Effectiveness of treating early-onset malignant schizophrenia with psychotropic drugs and their combinations Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 81(1): 114-121
Vohora, D. 2007: Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia Current Opinion in Investigational Drugs 8(7): 531-538
Crossland, J. 1971: Modern views on pharmacology. IV. Factors that influence the response to drugs Practitioner 206(234): 559-566
Khveshchuk, P.F.; Rakov, A.L.; Rudakova, A.V. 1999: Modern principles of supplying drugs to military medical establishments Voenno-Meditsinskii Zhurnal 320(5): 67-73
Lambert, M.; Naber, D.; Perro, C.; Moritz, S.; Krausz, M. 1999: Success of new treatments for schizophrenics, as shown by the example of modern antipsychotic drugs Psychiatrische Praxis 26(Suppl 1): S30-S35
Crossland, J. 1971: Modern views on pharmacology. 3. the absorption, distribution and excretion of drugs Practitioner 206(233): 422-428
Honerjäger, P.; Schmidt, G. 1993: Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 48(9): 425-429
Kulapina, E.G.; Barinova, O.V.; Kulapina, O.I.; Uts, I.A.; Snesarev, S.V. 2009: Modern methods of antibiotic determination in biological samples and drugs (review) Antibiotiki i Khimioterapiia 54(9-10): 53-60
Bowles, G.C. 1970: Modern pharmacy practice. N.A.S-N.R.C. reports efficacy of drugs released before 1962 Modern Hospital 115(1): 108
Shoshina, I.I.; Shelepin, I.E.; Semenova, N.B. 2014: The frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia with the therapy of atypical and typical antipsychotic drugs Fiziologiia Cheloveka 40(1): 43-48